US Court Pulls No Punches At It Denies Novartis Bid To Block MSN’s Entresto Generic
However, Court Imposes 72-Hour ‘Status Quo’ To Allow Novartis To Appeal
A US district court in Delaware was at times withering in its appraisals of Novartis’ defenses as it refused to grant an order that would block ANDA sponsor MSN Labs from selling a generic version of the multi-billion-dollar blockbuster Entreso.
